EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, SNDX: Syndax Pharma

12 Nov 25 15:59
LAST:

16.80

CHANGE:
 0.94		OPEN:
18.00		HIGH:
18.50		ASK:
9.15		VOLUME:
1.31M
CHG(%):
5.30		PREV:
17.73		LOW:
16.69		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 2517.5617.8016.6916.792.14M
11 Nov 2515.7617.7515.6717.733.53M
10 Nov 2515.3316.5015.2515.722.6M
07 Nov 2514.5715.0613.8815.042.16M
06 Nov 2515.0315.5514.6414.692.3M
05 Nov 2515.1215.2914.2715.103.36M
04 Nov 2513.6015.8013.1515.357.2M
03 Nov 2513.6114.3613.3513.764.14M
31 Oct 2513.3414.0613.3013.703.34M
30 Oct 2513.4113.9813.2513.392.21M

COMPANY PROFILE

Name:Syndax Pharma
About:Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:730 Third Avenue, New York, NY, United States, 10017
Website:https://syndax.com
CUSIP:87164F105
CIK:0001395937
ISIN:US87164F1057
FIGI:BBG000R33JY1
LEI:529900OF94TRHKZVBS87

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-3.70 
Forward P/E:-3.83 
PEG Ratio:-0.99 
Price to Sales:15.00 
Price to Book:7.42 
Profit Margin:0.97 
Operating Margin:-1.83 
Return on Assets:-0.40 
Return on Equity:-1.13 
EPS Ratio:-3.89 
Revenue:77.93M 
Shares:86.14M 
Market Cap:1.447B 

TECHNICAL INDICATORS

MA5:15.995.0%
MA10:15.1311.1%
MA20:14.7314.1%
MA50:15.2810.0%
MA100:13.5224.3%
MA200:12.9729.5%
STO9:75.37
STO14:78.46
RSI14:61.68 
WPR14:-20.35
MTM14:3.26
ROC14:0.24 
ATR:1.31 
Week High:17.806.0%
Week Low:13.8821.0%
Month High:17.806.0%
Month Low:12.9929.5%
Year High:17.876.4%
Year Low:8.5895.8%
Volatility:5.58